$ENLV News

Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $80

Enlivex Announces Trading Volume On Rain Protocol Reaches $860M

Enlivex Announces $400M Private Placement With A Single Institutional Investor Priced At $5.00 Per Share

Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why

Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA

Enlivex Holds 79.569B RAIN Token With Total Value Of ~$1.14B

Enlivex Receives Australian Patent Entitled 'Therapeutic Apoptotic Cells For Treatment Of Osteoarthritis'

Enlivex To Feature Extended 3-Month And 6-Months Clinical Data In Knee Osteoarthritis Phase Iia Trial At EULAR European Congress Of Rheumatology

EnLivex Doses First Patient In Its Phase 2b Clinical Trial Of Allocetra For Treatment Of Patients With Moderate-to-Severe Age-Related Symptomatic Primary Knee Osteoarthritis

Enlivex advances Allocetra while expanding into prediction markets

Enlivex Treasury Holdings Of RAIN Tokens Reaches 78,819,756,062 Tokens Valued At $567M

Enlivex Treasury Holdings Of RAIN Tokens Reaches 78,819,756,062 Tokens Valued At $567M

Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress

Enlivex Files Prospectus Related To Resale Of Up To 23.33M Shares By Selling Shareholder

Enlivex Announces Second Regulatory Approval From Danish Medicines Agency For Global Phase 2b Trial Of Allocetra In Age-Related Primary Knee Osteoarthritis

H.C. Wainwright Highlight Improved Balance Sheet Supporting Enlivex Ltd. (ENLV) Outlook

Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares

HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $20